Market Watch AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for marketing authorization in the European Union for advanced liver and lung…breakingnow_w51jcqDecember 19, 2022
